AU2001278610A1 - Pharmaceutical compositions comprising a modulator of adamts-1 - Google Patents
Pharmaceutical compositions comprising a modulator of adamts-1Info
- Publication number
- AU2001278610A1 AU2001278610A1 AU2001278610A AU7861001A AU2001278610A1 AU 2001278610 A1 AU2001278610 A1 AU 2001278610A1 AU 2001278610 A AU2001278610 A AU 2001278610A AU 7861001 A AU7861001 A AU 7861001A AU 2001278610 A1 AU2001278610 A1 AU 2001278610A1
- Authority
- AU
- Australia
- Prior art keywords
- adamts
- modulator
- pharmaceutical compositions
- pharmaceutical
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96486—Metalloendopeptidases (3.4.24)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0002973A SE0002973D0 (en) | 2000-08-22 | 2000-08-22 | Method |
SE0002973 | 2000-08-22 | ||
PCT/GB2001/003650 WO2002016632A1 (en) | 2000-08-22 | 2001-08-16 | Pharmaceutical compositions comprising a modulator of adamts-1 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001278610A1 true AU2001278610A1 (en) | 2002-03-04 |
Family
ID=20280755
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001278610A Abandoned AU2001278610A1 (en) | 2000-08-22 | 2001-08-16 | Pharmaceutical compositions comprising a modulator of adamts-1 |
Country Status (7)
Country | Link |
---|---|
US (1) | US20040014636A1 (en) |
EP (1) | EP1313874A1 (en) |
JP (1) | JP2004507468A (en) |
AU (1) | AU2001278610A1 (en) |
GB (1) | GB2381000A (en) |
SE (1) | SE0002973D0 (en) |
WO (1) | WO2002016632A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2305811A1 (en) * | 2005-07-27 | 2011-04-06 | Oncotherapy Science, Inc. | Method of diagnosing smal cell lung cancer |
WO2007147497A2 (en) * | 2006-06-17 | 2007-12-27 | Bayer Healthcare Ag | Use of a disintegrin-like and metalloproteinase with thrombospondin type 1 motif (adamts1) as a therapeutic or diagnostic target |
JP5809205B2 (en) * | 2013-07-16 | 2015-11-10 | 国立大学法人 東京大学 | Osteoporosis susceptibility gene and method for measuring osteoporosis risk |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0874050A3 (en) * | 1997-04-24 | 2002-06-05 | Smithkline Beecham Corporation | Integrin ligand ITGL-TSP |
US6565858B2 (en) * | 1997-06-03 | 2003-05-20 | Kureha Chemical Industry Co., Ltd. | Human ADAMTS-1 protein and pharmaceutical composition |
-
2000
- 2000-08-22 SE SE0002973A patent/SE0002973D0/en unknown
-
2001
- 2001-08-16 US US10/362,262 patent/US20040014636A1/en not_active Abandoned
- 2001-08-16 GB GB0301654A patent/GB2381000A/en not_active Withdrawn
- 2001-08-16 JP JP2002522302A patent/JP2004507468A/en active Pending
- 2001-08-16 AU AU2001278610A patent/AU2001278610A1/en not_active Abandoned
- 2001-08-16 WO PCT/GB2001/003650 patent/WO2002016632A1/en not_active Application Discontinuation
- 2001-08-16 EP EP01956689A patent/EP1313874A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2002016632A1 (en) | 2002-02-28 |
JP2004507468A (en) | 2004-03-11 |
GB0301654D0 (en) | 2003-02-26 |
GB2381000A (en) | 2003-04-23 |
US20040014636A1 (en) | 2004-01-22 |
EP1313874A1 (en) | 2003-05-28 |
SE0002973D0 (en) | 2000-08-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU781269C (en) | Pharmaceutical compositions | |
AU2001250420A1 (en) | Pharmaceutical compositions | |
AU2001224716A1 (en) | A medicinal aerosol formulation | |
AU2001274307A1 (en) | Pharmaceutical compositions | |
AU2001226233A1 (en) | A medicinal aerosol formulation | |
AU2001276934A1 (en) | Methods of modulating fibrosis | |
AU2002212254A1 (en) | Microcapsule powder | |
AU2001265933A1 (en) | Compounds with a sulphonamide group and pharmaceutical compositions containing these compounds | |
AU2002217464A1 (en) | Medicinal compositions containing aspirin | |
AU2001271037A1 (en) | Pharmaceutical compositions containing dds compounds | |
HUP0201591A2 (en) | Pharmaceutical formulations comprising an hiv protease inhibitor | |
AU2002214324A1 (en) | Medicinal compositions | |
AU2001266084A1 (en) | Pharmaceutical preparations comprising racecadotril (acetorphan) | |
AU2001224718A1 (en) | A medicinal aerosol formulation | |
AU2001273919A1 (en) | Pharmaceutical compositions | |
AU2002231656A1 (en) | Assembly comprising a plurality of mask containers | |
AU2001259318A1 (en) | A medicinal aerosol formulation | |
PL369268A1 (en) | A stable pharmaceutical composition of pravastatin | |
AU2001278610A1 (en) | Pharmaceutical compositions comprising a modulator of adamts-1 | |
AU4085201A (en) | Pharmaceutical composition | |
AU2002246659A1 (en) | Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds | |
AU2001227531A1 (en) | A medicinal aerosol formulation | |
AU2001247123A1 (en) | A medicinal aerosol formulation | |
AU2001288325A1 (en) | Pharmaceutical compounds useful as modulators of endocannabinoid-mediated response | |
AU2001278705A1 (en) | Pharmaceutical composition |